We curate a digest of the latest news in our field for advocates, policymakers, community coalitions and all who work toward shaping policies and practices to effectively prevent substance use and treat addiction.
State legislators around the country are seeking harsher penalties for possessing fentanyl and other synthetic opioids, despite evidence showing harm reduction and treatment are needed more, AP reports.
California Governor Gavin Newsom is calling for a measure on the 2024 ballot that would fund a major expansion of housing and treatment for residents experiencing mental illness and substance use disorders, AP reports.
The $21 billion opioid settlement brokered last year between the three largest U.S. pharmaceutical distributors and the attorneys general of 46 states has made it more difficult for some patients to obtain other types of medications, including those for addiction, anxiety and attention deficit hyperactivity disorder, according to The New York Times.
A new study finds that opioids were responsible for more than half of all fatal poisonings in children under age 5 in 2018. The rate of fatal opioid poisonings in young children has doubled since 2005, CNN reports.
Some addiction experts are hopeful that more patients will be treated with the opioid use disorder medication buprenorphine now that Congress has made it easier for doctors to prescribe it, NPR reports. But others are concerned stigma could undermine efforts to expand access.
Data from the Food and Drug Administration on its confiscation of packages containing substances coming through international mail shows few of them contain opioids, Kaiser Health News reports. The overwhelming majority of the packages were uncontrolled prescription medications that people had ordered, such as generic Viagra.
The U.S. Food and Drug Administration announced this week it is taking action to restrict illegal importing of the veterinary pharmaceutical xylazine, which has increasingly been found in illicit fentanyl and involved in a growing number of overdose deaths.
The Drug Enforcement Administration is proposing to reinstate federal rules, waived during the pandemic, that require patients to see a doctor in person to receive an initial prescription for controlled medicines such as OxyContin or Adderall.
After a Food and Drug Administration advisory panel voted to make the nasal spray version of the opioid overdose antidote naloxone (Narcan) available without a prescription, experts say the medication’s cost will determine how many people can benefit from it.